Quantcast

[Significance of prostate central gland/total gland volume ratio combined with PSA in the diagnosis of prostate cancer patients].

Research paper by Z F ZF Guo, X W XW Lu, F F Yang, J W JW Wu, H H Wang, C C He

Indexed on: 22 Dec '20Published on: 26 Sep '19Published in: Zhonghua yi xue za zhi



Abstract

To explore the significance of prostate central gland/total gland volume (PVc/PV) ratio combined with PSA in the diagnosis of PSA 4-20 ng/ml prostate cancer patients. Data of patients undergoing prostate puncture in Minghang Branch, Zhongshan Hospital from July 2015 to December 2018 were retrospectively analyzed. The anteroposterior, transverse and axial diameters of the prostate and the central prostate gland were measured by magnetic resonance imaging (MRI). The differences of tPSA, f/tPSA, PSAD and PVc/PV between the prostate cancer group and non-prostate cancer group were compared. Receiver operating characteristic (ROC) curves of prostate cancer diagnosis were plotted according to tPSA, f/tPSA, PSAD, PVc/PV alone and PVc/PV combined with tPSA, respectively, and the area under the curve (AUC) was calculated and compared using tPSA as the reference. There was no significant difference in tPSA between the two groups (0.05). However, significant differences were observed in f/tPSA, PSAD and PVc/PV between the two groups (0.05). The AUC value of PVc/PV combined with tPSA, PVc/PV and PSAD was 0.901 2,0.866 7 and 0.848 1,respectively, which were statistically different from that of tPSA (0.05). The AUC value of f/tPSA was 0.716, which was not statistically different from that of tPSA (0.05). The PVc/PV ratio combined with tPSA can be used as an important reference index for the diagnosis of prostate cancer in PSA 4-20 ng/ml patients.